NCT00134056
Clinical Trial Information
Trial Number: NCT00134056 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
Study ID:
S0421
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00134056-D1 | This dataset contains quality of life (QOL) data from trial NCT00134056 to reproduce the results reported in the Journal of Patient-Reported Outcomes (Unger et al, JPRO, 2018, PMID29951640). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®